Rheumatoid Arthritis
We invite you to participate in a clinical trial evaluating a novel oral treatment combined with standard care (Methotrexate) to investigate the potential to resolve the inflammation causing your symptoms.
Qualification Requirements
- Men and Women
- Age 18 years or older (≥18 years)
- Recently diagnosed with Rheumatoid Arthritis
COMPENSATION UP TO: $1,190
Study Details
This clinical research trial focuses on Rheumatoid Arthritis (RA), a chronic autoimmune disease known for causing inflammation, pain, stiffness, and damage in the joints, often leading to significant disability and reduced quality of life. Despite available therapies, many individuals continue to experience active disease and persistent symptoms. This highlights the ongoing need for exploring new and potentially more effective treatment options. The primary objective of this study is to evaluate the effectiveness and safety of a novel therapeutic approach aimed at reducing inflammation, alleviating symptoms, and improving physical function in adults living with RA.
Enrollment is open to adult men and women aged 18 years and older who have a confirmed medical diagnosis of Rheumatoid Arthritis. A key requirement for participation is evidence of active Rheumatoid Arthritis, despite receiving current or previous standard treatments. These criteria help ensure the study includes participants whose disease activity warrants evaluation of a new or alternative approach, focusing on those who may benefit most from the potential intervention being studied.